| The Lancet Commission on diabetes: using data to transform diabetes care and patient lives JCN Chan, LL Lim, NJ Wareham, JE Shaw, TJ Orchard, P Zhang, ... The Lancet 396 (10267), 2019-2082, 2020 | 630 | 2020 |
| Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices: an updated review A Monnette, Y Zhang, H Shao, L Shi Pharmacoeconomics 36, 17-27, 2018 | 85 | 2018 |
| Novel Risk Engine for Diabetes Progression and Mortality in USA: Building, Relating, Assessing, and Validating Outcomes (BRAVO) H Shao, V Fonseca, C Stoecker, S Liu, L Shi PharmacoEconomics 36 (9), 1125-1134, 2018 | 82 | 2018 |
| Cost effectiveness of sodium-glucose cotransporter-2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and dipeptidyl peptidase-4 (DPP-4) inhibitors: a … D Hong, L Si, M Jiang, H Shao, W Ming, Y Zhao, Y Li, L Shi Pharmacoeconomics 37, 777-818, 2019 | 77 | 2019 |
| Is hypoglycemia fear independently associated with health-related quality of life? L Shi, H Shao, Y Zhao, NA Thomas Health and quality of life outcomes 12, 1-9, 2014 | 73 | 2014 |
| Evaluation of a remote monitoring system for diabetes control B Katalenich, L Shi, S Liu, H Shao, R McDuffie, G Carpio, T Thethi, ... Clinical therapeutics 37 (6), 1216-1225, 2015 | 70 | 2015 |
| Disparities in 30-day readmissions after total hip arthroplasty CIA Oronce, H Shao, L Shi Medical care 53 (11), 924-930, 2015 | 66 | 2015 |
| Estimating quality of life decrements due to diabetes complications in the United States: the Health Utility Index (HUI) diabetes complication equation H Shao, S Yang, V Fonseca, C Stoecker, L Shi Pharmacoeconomics 37, 921-929, 2019 | 56 | 2019 |
| Factors contributing to the rising national cost of glucose-lowering medicines for diabetes during 2005–2007 and 2015–2017 X Zhou, SS Shrestha, H Shao, P Zhang Diabetes Care 43 (10), 2396-2402, 2020 | 52 | 2020 |
| Newer glucose‐lowering drugs and risk of dementia: a systematic review and meta‐analysis of observational studies H Tang, H Shao, CE Shaaban, K Yang, J Brown, S Anton, Y Wu, A Bress, ... Journal of the American Geriatrics Society 71 (7), 2096-2106, 2023 | 46 | 2023 |
| Potential gains in life expectancy associated with achieving treatment goals in US adults with type 2 diabetes H Kianmehr, P Zhang, J Luo, J Guo, ME Pavkov, KMK Bullard, EW Gregg, ... JAMA network open 5 (4), e227705-e227705, 2022 | 46 | 2022 |
| Evaluating the ability of economic models of diabetes to simulate new cardiovascular outcomes trials: a report on the ninth mount hood diabetes challenge L Si, MS Willis, C Asseburg, A Nilsson, M Tew, PM Clarke, M Lamotte, ... Value in Health 23 (9), 1163-1170, 2020 | 44 | 2020 |
| Cost-effectiveness analysis of dapagliflozin versus glimepiride as monotherapy in a Chinese population with type 2 diabetes mellitus H Shao, S Zhai, D Zou, MU Mir, NK Zawadzki, Q Shi, S Liu, L Shi Current Medical Research and Opinion 33 (2), 359-369, 2017 | 36 | 2017 |
| A systematic review of cost-effectiveness of sodium-glucose cotransporter inhibitors for type 2 diabetes Y Yoshida, X Cheng, H Shao, VA Fonseca, L Shi Current diabetes reports 20, 1-19, 2020 | 31 | 2020 |
| Feasibility study on hyperspectral LiDAR for ancient Huizhou-style architecture preservation H Shao, Y Chen, Z Yang, C Jiang, W Li, H Wu, S Wang, F Yang, J Chen, ... Remote Sensing 12 (1), 88, 2019 | 31 | 2019 |
| Readmission due to infection following total hip and total knee procedures: a retrospective study N Zawadzki, Y Wang, H Shao, E Liu, C Song, M Schoonmaker, L Shi Medicine 96 (38), e7961, 2017 | 31 | 2017 |
| Cost sharing of disease-modifying treatments (DMTs) as policy lever to improve DMTs’ access in multiple sclerosis H Shao, C Stoecker, AM Monnette, L Shi Value in Health 21 (9), 1083-1089, 2018 | 30 | 2018 |
| Evaluating excessive burden of depression on health status and health care utilization among patients with hypertension in a nationally representative sample from the Medial … H Shao, MU Mohammed, N Thomas, S Babazadeh, S Yang, Q Shi, L Shi The Journal of Nervous and Mental Disease 205 (5), 397-404, 2017 | 29 | 2017 |
| Estimating costs of diabetes complications in people< 65 years in the US using panel data W Yang, I Cintina, T Hoerger, SJ Neuwahl, H Shao, M Laxy, P Zhang Journal of Diabetes and its Complications 34 (12), 107735, 2020 | 28 | 2020 |
| Using the BRAVO risk engine to predict cardiovascular outcomes in clinical trials with sodium–glucose transporter 2 inhibitors H Shao, L Shi, VA Fonseca Diabetes Care 43 (7), 1530-1536, 2020 | 26 | 2020 |
